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Stogether. Transaortic resection of basal chordae of the ante-
rior leaflet is also expected to relieve tension on the leaflet
and enhance mobility of the mitral leaflets, but concern
has been expressed regarding the role of these particular
chordae in ventricular remodeling.
The papillary muscle sling has a double effect:
1. The sling addresses the mitral valve by proposing a repair
that takes the mitral apparatus into account as a whole
functioning unit. Furthermore, by suppressing the possi-
bility of continual lateral papillary muscle displacement,
the sling prevents recurrent mitral leaks. None of our pa-
tients with an initially perfect result, although the mean
follow-up is only of 36 months, showed any secondary
change compared with the initial result.
2. The sling also addresses the left ventricle. By this trans-
mitral approach, plicating the posterior wall of the left
ventricle from the inside, the sling acutely changes the
shape and the volume of the left ventricle. Shortening
the posterior LV free wall between the bases of the two
PMs (Figure 3) has an effect on regional wall motion.
Echocardiographic follow-up in our patients, who were
all poor or borderline responders in terms of predictable
remodeling, show that the LV diameters consistently
shorten, ejection fraction increases, volumes melt, sphe-
ricity indexes improve, and the LV walls thicken,
whereas functional status and survival are excellent.
Acute surgical remodeling of the local LV anomalies
that focus on the subvalvular mitral apparatus may there-
fore have long-term beneficial effect that will cumulate
with the already consistent effect of mitral valvuloplasty.CONCLUSIONS
Mitral repair by means of a sling encircling and reapprox-
imating both PMs, setting a more normal ‘‘PM–mitral annu-
lus’’ anatomic relationship, completed by mitral
annuloplasty seems a more rational approach in patients
with ischemic MR. It restores mitral leaflet mobility, pre-
vents recurrent MR, and shows an effect on ventricular
dynamics in patients who are normally considered as poor
responders to an undersized ring.References
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Dr Robert A. Dion (Genk, Belgium). Dr Hvass, as you men-
tioned, our group in Leiden has demonstrated that a preoperative
cutoff value of the LV end-diastolic diameter of 65 mm is an inde-
pendent predictor of survival and of LV reverse remodeling. Below
this value, a stringent undersizing annuloplasty by two sizes using
a complete semirigid ring (Physio ring), as you also now use, yields
a coaptation length of at least 8 mm. In our hands, this is invariably
efficient in correcting MR without producing mitral stenosis and
also addresses LV remodeling, even after a follow-up of 5 years.
We also concluded that something else should be added to the
annuloplasty at the ventricular level in the presence of a more
dilated left ventricle, in case the LV end-diastolic diameter is
more than 65 mm.
There are, in my opinion, two ways to address the ventricular
level: either from the outside, such as using the CorCap, as we
have chosen in Leiden with initial promising results, or from the
inside, such as the PM resuspension described by Irving Kron
and his group, or the PM approximation by stitches proposed by
Matsui from Japan, or the PM sling that you already proposed
a while ago.ery c February 2010
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SI have been convinced by this brilliant idea and have used it in
addition to restrictive mitral annuloplasty in patients with dilated
ventricles exceeding 65-mm end-diastolic dimension with promis-
ing short-term results. Your patient cohort has a mean preoperative
LV end-diastolic diameter of 70 mm and therefore indeed corre-
sponds to the Leiden cohort, which had disappointing results:
a mortality of 50% at 5 years and an absent or less significant re-
verse remodeling in only 50% of the survivors. Only 2 of 29 pa-
tients in your group died after 3 years and 2 others required
a reoperation. This is a spectacular result, certainly if one considers
the amount of continuous reverse remodeling that you described
over 1 year.
I have a few questions. What is your current indication for per-
forming a PM sling in this group? Do you perform it systematically
or only in the presence of a dilated ventricle with more than 65-mm
end-diastolic diameter? Do you also take into account the inter-PM
distance, as Matsui recommends, doing something above 3 cm?
Dr Hvass. To answer the first question, I must admit that I do
not see the good responders. I am essentially having referred to me
the patients who already have very enlarged ventricles. It is more
or less a systematic approach since I am not seeing the other
patients, and I have been using it in all of these patients. It is
true that in all of these patients, the distance of the PMs is much
more than 3 cm.
Dr Dion. Thank you. In the last 10 patients, you write in the
manuscript that you no longer undersized the annuloplasty ring.
Did you measure the length of coaptation in these patients in
whom you did a sling with no restrictive mitral annuloplasty?
Dr Hvass. In the first group of patients, the ring was hardly un-
dersized. I mean, it was not two sizes. I was using the size of the
anterior leaflet as a guideline and sometimes wondering whether
I should undersize it or not, just for safety. Then when I became
very confident with the technique, I just took the normal size and
have been continuing that way. You do not need to undersize mitral
rings. When you have the mitral rings together, you have much
more mobility of the leaflets.
The height of the coaptation is very good. I do not try to get 8
mm each time, as you advocate, but it is between 5 and 8 mm in
all the cases. We never have very, very shallow coaptation heights
with this technique.
Dr Dion. Thank you. In my limited experience with your tech-
nique, I ended up in a 5-year-old child after the sling with a prolapse
of A1, A2, P1 after approximation of the PMs, probably because I
approximated the PMs with different heights. Did you encounter
this problem and have you considered additionally stitching to-
gether the tips of the PMs to prevent this problem and reinforce
your intraventricular repair?
Dr Hvass. I remember you talked about this problem with me
already, and I was a bit surprised because I have not encountered
it in any of my patients. I do not know how I would deal with it.
I do not know whether it would be necessary to put an additional
stitch at the tip of the PMs or not.The Journal of Thoracic and CaDr Steven F. Bolling (Ann Arbor, Mich). I disclose I have IP and
royalty rights to the GeoForm ring.
Dr Hvass, congratulations on your pioneering work. This clearly
is a ventricular problem and you have proposed a very interesting
operation that perhaps is technically demanding for the rest of us.
I have a particularly technical question. We know now that the clo-
sure cylinder of the mitral valve apparatus should be stacked as
a cylinder. Do you measure the sling, do you make it the same
size and diameter as the annuloplasty ring, or how do you size
the sling?
Dr Hvass. I do not size it. I just put it around the PMs and bring
the PMs into contact. That is the only measure I do. It has nothing to
do with the size of the mitral ring above it. It may not be a complete
cylinder, but that is the way I have been doing it.
Dr Richard J. Shemin (Los Angeles, Calif). No disclosures.
I have another question about intraoperative decision-making.
Obviously, there is often variability in the sizes and the distribution
of PMs, so what have you learned from your experience of when
not to do this, and are PMs that are asymmetrical a problem in get-
ting a good result?
Dr Hvass. As you saw from the slides, there was an initial mis-
take when I did leave a group of PMs out. I am very careful now to
look at the exact anatomy, what is happening below, and go around
all the PMs that are there.
DrR.W.M. Frater (Bronx, NY).Have you ever had to turn a pa-
tient down because of the irregularity of the anatomy?
Dr Hvass. No. I think it is quite unusual to have what is called
a type 4 mitral PM anatomy. I think it is very unusual.
Dr David H. Adams (New York, NY). Dr Hvass, I would like to
make a comment and then ask you a question. I think we have to
stop presenting slides that say that current strategy fails in 20%
to 50% of these patients. A lot of those patients were not down-
sized; a lot of those patients received partial flexible bands, which
is not done in most centers. We should start talking about patients
who had downsized remodeling rings and what that standard is
from Leiden and others as the benchmark. There is a recurrence
rate, probably 10% or 15%, but I think it is historical now to say
50% of ischemic MR repairs fail. I think it sets the bar too low
from the percutaneous side.
Having said that, I congratulate you for this really unique work
in trying to move PMs, but I am going to ask you for some more
science. Can you tell us about tethering angle, tethering area, and
depth of coaptation? Your MR grades were grade 2 to 4, so you
can have a big ventricle and still have mild MR. I am impressed
by your remodeling, but do you have more precise echo data on
the amount of tethering and what you are doing to that after you
do this operation compared with just annuloplasty?
Dr Hvass. We have data on the preoperative and postoperative
tethering, which I have been showing in all the previous meetings. I
decided not to show it this time because most people know it. We
have had the preoperative tethering that is going from 16mm to less
than 4 mm. There was a big, big change in that.rdiovascular Surgery c Volume 139, Number 2 423
